Medication Adherence

Resource Center

Q&As

Expert Q&A

12/09/2022

In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...

12/09/2022

Research Summaries

FDA Alert

FDA Approves First Treatment for Adults With NASH, Serious Liver Disease

03/21/2024

Anthony Calabro, MA

The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.

03/21/2024

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

Research Summary

Among Patients With Atherosclerotic Cardiovascular Disease Who Are Eligible For High-Intensity Statins, Most Are Not Using Them

01/26/2024

Jessica Ganga

Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.

01/26/2024

Research Summary

Pausing Adjuvant Endocrine Therapy to Attempt Pregnancy Shows No Additional Short-Term Risk For Select Women With Early-Stage Breast Cancer

01/12/2024

Anthony Calabro, MA

In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.

01/12/2024

research summary

research summary

Directly Observed Therapy Accurately Measures PrEP Adherence

09/26/2023

Leigh Precopio

Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...

09/26/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4